Metformin Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma through Circ_0003214-Mediated MiR-489-3p-ADAM10 Pathway
CONCLUSION: Metformin inhibits HSCC progression through the circ_0003214/miR-489-3p/ADAM10 pathway.PMID:34335751 | PMC:PMC8295003 | DOI:10.1155/2021/2265475
Source: Journal of Oncology - Category: Cancer & Oncology Authors: Xiaoqiang Chen Chen Li Wei Chen Shuchun Lin Xuehan Yi Qin Lin Hao Xu Desheng Wang Source Type: research
More News: Cancer & Oncology | Carcinoma | Fortamet | Genetics | Hypopharyngeal Cancer | Metformin | Skin Cancer | Squamous Cell Carcinoma | Study